In our series of letters from African journalists, scientists and academics assess the safety and tolerability of Ebola vaccinations in Africa. The BBC's weekly The Lancet profiles different researchers from around the world, from across the continent.
Source: journals.plos.orgPublished on 2022-01-11
Related news
- New Analyses of Two AZD7442 COVID - 19 Phase III Trials in High - Risk Populations Confirm Robust Efficacy and Long - Term Prevention
- AZD7442 reduced risk of developing severe COVID - 19 or death in TACKLE Phase III outpatient treatment trial
- AstraZeneca plc ( via Public ) / AZD7442 reduced risk of developing severe COVID - 19 or death in TACKLE Phase III outpatient treatment trial
- Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC : AZD7442 PhIII trial positive in COVID outpatients
- Safety and immunogenicity of 2 - dose heterologous Ad26 . ZEBOV , MVA - BN - Filo Ebola vaccination in healthy and HIV - infected adults : A randomised , placebo - controlled Phase II clinical trial in Africa